michigan semaglutide digestive blockage lawsuit GLP-1 Lawsuits: What to Know as a Prescriber Ozempic GLP-1 Lawsuit & Gastroparesis
Description
Jesse is a Partner in Frier Levitt's Pharmacy Law Group with a focus on payor issues and litigation.
KPBS Midday Edition wants to hear from you
Semaglutide, a GLP-1 receptor agonist, has been clinically proven to aid in weight reduction and improve glycemic control
Conclusions/interpretation In a population with type 2 diabetes and high risk of CVD, semaglutide and empagliflozin significantly reduced cortical ADC compared with placebo, indicating microstructural changes in the kidneys
